SCHEMBL3409944

SCHEMBL3409944

CCOC(=O)c1cnc(Nc2ccc(-c3nc(C)c[nH]3)c(OC)c2)nc1CCC=C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
NPC1 O15118 1/20 0.42
BRD4 O60885 1/20 0.42
NPSR1 Q6W5P4 2/20 0.39
IMPDH2 P12268 1/20 0.38
PAK1 Q13153 1/20 0.37
SIRT5 Q9NXA8 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
MAPK8 P45983 1/20 0.36
MAPK9 P45984 1/20 0.36
MAP4K3 Q8IVH8 1/20 0.36
MAP4K1 Q92918 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
CDK2 P24941 1/20 0.36
CDK9 P50750 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
DPP4 P27487 3/20 0.35
TP53 P04637 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3410539 0.85 MAPT (0.43) MAPTNPC1BRD4NPSR1IMPDH2
SCHEMBL3412922 0.83 IMPDH2 (0.39) IMPDH2MAPK8MAPK9
SCHEMBL4101444 0.81 PSEN1 (0.48) MAPTNPC1BRD4
SCHEMBL3407097 0.81 BRD4 (0.41) MAPTNPC1BRD4IMPDH2PAK1
SCHEMBL3411191 0.80 BRD4 (0.45) MAPTNPC1BRD4IMPDH2PAK1
SCHEMBL3412596 0.80 PLK1 (0.42) MAPTNPC1BRD4IMPDH2PAK1
SCHEMBL3411147 0.79 BRD4 (0.46) MAPTNPC1BRD4PAK1CDK2
SCHEMBL3410218 0.79 IMPDH2 (0.41) MAPTNPC1BRD4IMPDH2PAK1
SCHEMBL3412096 0.79 BRD4 (0.46) MAPTNPC1BRD4IMPDH2PAK1
SCHEMBL3412246 0.78 SYK (0.42) MAPTNPC1BRD4IMPDH2PAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257541-A1 MODULATORS FOR AMYLOID BETA F. Hoffmann-La Roche AG (CH) 2010-12-08 EP disclosed
WO-2009103652-A1 MODULATORS FOR AMYLOID BETA F. HOFFMANN-LA ROCHE AG (CH) 2009-08-27 WO disclosed